Health Care/Hospital
AWAK TECHNOLOGIES RAISES US$20+ MILLION, READYING ITS WEARABLE DIALYSIS DEVICE FOR US-BASED PIVOTAL TRIAL
* AWAK closes one of the largest MedTech fundraise in 2023 in Southeast Asia * The Series B round was co-led by new investor Lion X Ventures and long-term investor Vickers Venture Partners, along with other new and existing investors * AWAK's ultra-portable peritoneal dialysis system enables ...
2023-09-13 21:27
2154
S-Patch Ex, Wearable ECG Patch, Cleared by US FDA
* Lightest weighing ECG patch in the market designed for comfort and ease of use * Embedded with Samsung's Next-Generation bio-processor proven to capture world's most accurate ECG waveforms SEOUL, South Korea, Sept. 13, 2023 /PRNewswire/ -- Wellysis, a spin-off company from Samsung SDS, has ...
2023-09-13 21:00
1723
Health In Tech's eDIYBS Takes Center Stage at SIIA
Health In Tech to showcase how quickly it's eDIYBS technology can quote groups at this year's SIIA National Conference. STUART, Fla., Sept. 13, 2023 /PRNewswire/ -- Health In Tech, an industry-leading insurtech company that delivers disruptive innovation and re-imagines self-funded health plans,...
2023-09-13 20:30
1314
Exelixis and Insilico Medicine Enter into Exclusive Global License Agreement for ISM3091, a Potentially Best-in-Class USP1 Inhibitor
— ISM3091 is a highly selective, orally bioavailable small molecule inhibitor of USP1 identified through Insilico Medicine's artificial intelligence (AI) platform, with potent activity in BRCA-mutated tumor models — — In May 2023, the U.S. Food and Drug Administration (FDA) cleared Insilico's I...
2023-09-13 20:29
1695
Global Times: Witness to history: Chinese people in Morocco share life-and-death earthquake experiences, rush to assist locals to get through disaster
BEIJING, Sept. 13, 2023 /PRNewswire/ -- At 1.28 am, obstetrician Zhang Qian finally heard the loud cry of a baby. It was a healthy baby girl. Zhang breathed a sigh of relief performing after a nerve-racking hour-long C-section on a Moroccan patient. While in surgery at a Moroccan hospital, Zhang ...
2023-09-13 19:48
1518
Asieris Announces Positive Interim Analysis Results in Phase II Clinical Trial of Oral APL-1202 in Combination with Tislelizumab, a PD-1 inhibitor, as Neoadjuvant Therapy for Muscle Invasive Bladder Cancer
SHANGHAI, Sept. 13, 2023 /PRNewswire/ -- Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that the clinical trial of oral APL-12...
2023-09-13 19:09
1359
Singleron launches AccuraCode® TCR library construction kit, enhancing efficiency and cost-effectiveness of high-throughput T-cell receptor profiling
COLOGNE, Germany, Sept. 13, 2023 /PRNewswire/ -- Singleron has announced the launch of its AccuraCode® TCR library construction kit for high-throughput T-cell receptor (TCR) profiling. It enables simultaneous analysis of hundreds of samples for T cell clonotypes, gene usage, V(D)J recombination p...
2023-09-13 17:51
1249
J INTS BIO, WCLC 2023 - Presentation of Phase 1/2 study of 'JIN-A02', a Novel Oral 4th Generation EGFR TKI
SEOUL, South Korea, Sept. 13, 2023 /PRNewswire/ -- J INTS BIO announced that Phase 1/2 study of its novel, orally administered 4th generation EGFR-TKI 'JIN-A02' was presented at the 2023 IASLC World Conference on Lung Cancer held inSingapore from 9th to 12th September, during the official session...
2023-09-13 15:58
1510
Zuberitamab (Anruixi®), the first domestically developed anti-CD20 antibody as a Class I innovative drug from BioRay Pharmaceutical, has been approved for marketing in China
SHANGHAI, Sept. 13, 2023 /PRNewswire/ -- Recently, BioRay Pharmaceutical Co., Ltd. (hereinafter referred to as "Bioray") announced that its independently developed Class I innovative therapeutic biological product, Zuberitamab Injection (trade name: Anruixi®), indicated for the treatment of CD20...
2023-09-13 14:24
1311
Caliway Announces CBL-514 Phase 2 Study Topline Results for Dercum's Disease, Showing 64.5% of Lipomas with Complete Clearance or Dimensions Reduction of Over 50% and Reduced Pain by 4.7
- CBL-0201DD Phase 2 study met the primary and all secondary endpoints. - 64.5% of painful lipomas showed complete clearance or dimensions reduction of more than 50% after CBL-514 treatments. - 54.8% of painful lipomas showed complete clearance or dimension reduction of more th...
2023-09-13 13:42
1218
AIRS Medical Inc. receives MDSAP Certification, Paving the Way for Global Expansion
SEOUL, South Korea, Sept. 13, 2023 /PRNewswire/ -- AIRS Medical Inc., an AI-powered healthcare solution provider headquartered in Korea announces the attainment of MDSAP (Medical Device Single Audit Program) certification. This milestone achievement underscores AIRS Medical's commitment to qualit...
2023-09-13 12:44
1311
91% of doctors in Southeast Asia participate in digital learning despite societal return to in-person interactions - Docquity
* Docquity survey shows that doctor attendance at digital learning events is higher than in-person events (at 3.9 versus 3.0 times per month) * While two learning cohorts have emerged - digital dominant learners and in-person dominant learners, both groups participate in digital learning yet ...
2023-09-13 10:55
679
Menarini Asia-Pacific Enters into an Exclusive Licensing Agreement with Astellas to Commercialize Smyraf® in Taiwan and select South-East Asian markets
SINGAPORE, Sept. 13, 2023 /PRNewswire/ -- Menarini Asia-Pacific has entered into a long-term exclusive licensing partnership with Astellas Pharma Inc. (Astellas) for the development, manufacturing and commercialization of the orally administered Janus kinase (JAK) inhibitor Smyraf® 50 mg and 100 ...
2023-09-13 10:30
2309
Maxigen Biotech Inc. Wins 2023 Asia's Leading SMEs Award for Innovative Sustainability
KUALA LUMPUR, Malaysia, Sept. 13, 2023 /PRNewswire/ -- Maxigen Biotech
Inc.(MBI), a pioneering biotech company headquartered inTaiwan, has been
honored with the prestigious 2023 Asia's Leading SMEs Award by ACES
underscoring its commitment to innovation and sustainable operations.
2023-09-13 09:30
1909
GemPharmatech's Board Appoints Brandy Wilkinson, Ph.D. as its New Chief Executive Officer of GemPharmatech LLC.
SAN DIEGO, Sept. 12, 2023 /PRNewswire/ -- GemPharmatech LLC., a leading
contract research organization, announced today that its Board of Directors has
appointed Dr.Brandy Wilkinson as the Chief Executive Officer of its subsidiary
inthe United States, effective September 12, 2023.
2023-09-13 00:00
1387
"Promoting Health, Wellness, and Community: Gowalking.com Unites Global Fitness Walkers for a Better World"
BOCA RATON, Fla., Sept. 12, 2023 /PRNewswire/ -- Today marks the launch of Gowalking.com, a groundbreaking start-up founded byJeremy Goldstein, with a mission to connect and empower the world's estimated 1.2 billion fitness walkers by providing a simple and innovative platform for finding and joi...
2023-09-12 22:30
2575
Medmain Inc. Has Been Selected for the U.S. Market Gateway Accelerator for BioSciences and MedTech
FUKUOKA, Japan, Sept. 12, 2023 /PRNewswire/ -- Medmain Inc. (
https://en.medmain.com
2023-09-12 22:00
1556
Frost & Sullivan Recognizes Suki AI with the 2023 North American Technology Leadership Award
Suki's innovative AI Assistant brings the power of Generative AI to health systems and delivers strong ROI SAN ANTONIO, Sept. 12, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the healthcare voice assistant industry and, based on its findings, recognizesSuki AI with the 2023 North Am...
2023-09-12 22:00
1651
TMRW Life Sciences Receives CE Mark for the CryoRobot Select, its Next-Generation Automated Platform to Safely Manage and Store Frozen Eggs and Embryos
TMRW's Cutting-Edge Technology is Raising the Standard of Care in Global Fertility NEW YORK, Sept. 12, 2023 /PRNewswire/ -- TMRW Life Sciences, a fertility technology company automating the IVF lab, today announced that it has received a CE Mark for the CryoRobot Select (CRS). The European desig...
2023-09-12 21:01
1569
Standigm's "Green Ribbon Campaign" to support Mitochondria Disease Awareness Week
SEOUL, South Korea, Sept. 12, 2023 /PRNewswire/ -- On September 5th, 2023 Standigm, a company using artificial intelligence (AI) technology for drug discovery and development launched, the "Green Ribbon Campaign," event to support the upcoming Mitochondrial Disease Awareness Week scheduled for Se...
2023-09-12 21:00
1291
Week's Top Stories
Most Reposted
k-ID Closes $45 Million Series A from Andreessen Horowitz and Lightspeed Venture Partners to Set a New Global Benchmark for Age-appropriate Gaming Experiences
[Picked up by 320 media titles]
2024-06-25 21:00
10 Start-ups Awarded in HK Tech 300 Southeast Asia Start-up Competition Fostering Innovation & Entrepreneurship Beyond Boundaries
[Picked up by 320 media titles]
2024-06-27 18:56
Labuan IBFC Inc. and STEP Malaysia jointly host wealth management and estate planning event
[Picked up by 318 media titles]
2024-06-28 12:45
Yidu Tech Announces Annual Results for FY 2024: Existing Business Achieves First Full-Year Profit on Adjusted EBITDA
[Picked up by 289 media titles]
2024-07-01 09:05
Fibocom Drives the Rapid Growth in the Economics of IoT Scale with Ultra-compact size Cat 1 bis Module MC610-GL at MWC Shanghai 2024
[Picked up by 286 media titles]
2024-06-26 10:00
Most Read
k-ID Closes $45 Million Series A from Andreessen Horowitz and Lightspeed Venture Partners to Set a New Global Benchmark for Age-appropriate Gaming Experiences
2024-06-25 21:00
13647
Lilyannie Christie Linus Crowned Miss Grand Malaysia Sabah 2024
2024-06-25 13:38
12486
